GGrantIndex
Sort

40,608 grants matching prostate cancer

Core D: Data Management, Biostatistics, and Bioinformatics

$343,825
David V Conti · University Of Southern California · U19 · FY2019 · CA

Project 1: Non-Invasive Clinical Assay for Early Detection of Treatment Resistance in Patients with Metastatic Prostate Cancer

$343,785
Himisha Beltran · Weill Medical Coll Of Cornell Univ · P50 · FY2019 · CA

Project 1: Non-Invasive Clinical Assay for Early Detection of Treatment Resistance in Patients with Metastatic Prostate Cancer

$343,785
Himisha Beltran · Weill Medical Coll Of Cornell Univ · P50 · FY2021 · CA

MiR-183-96-182 cluster, prostatic zinc homeostasis and carcinogenesis

$343,763
Larisa Nonn · University Of Illinois At Chicago · R01 · FY2014 · CA

RANKL and BMPs in Prostate Cancer Induced Bone Lesions

$343,763
University Of California Los Angeles · R01 · FY2005 · CA

Regulation of a DNA damage response network in glioblastoma

$343,754
Andy J Minn · University Of Pennsylvania · R01 · FY2013 · CA

Protein Biosensor Arrays Based on Nanomaterials

$343,745
James F. Rusling · University Of Connecticut Storrs · R01 · FY2012 · EB

Initiation and Regulation of Chronic Autoimmune Prostate Inflammation

$343,736
Timothy L Ratliff · Purdue University · R01 · FY2012 · DK

Genetically Engineered Viruses for Prostate Cancer Therapy

$343,732
Robert L Martuza · Massachusetts General Hospital · R01 · FY2010 · CA

Brain-Selective Therapy to Alleviate Hot Flushes of Prostate Cancer Patients

$343,697
Laszlo Prokai · University Of North Texas Hlth Sci Ctr · R01 · FY2018 · CA

Medical Care Burden of Cancer: System and Data Issues

$343,694
Mark Christopher Hornbrook · Kaiser Foundation Research Institute · R01 · FY2009 · CA

Racial Segregation & Disparities in Cancer Outcomes

$343,682
Jennifer S Haas · Brigham And Women'S Hospital · R01 · FY2006 · CA

LOCALIZATION OF SUSCEPTIBILITY LOCI IN PROSTATE CANCER

$343,659
Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2002 · CA

CENTER FOR BIOMEDICAL RESEARCH

$343,646
Clayton Yates · Tuskegee University · G12 · FY2015 · MD

Racial Segregation & Disparities in Cancer Outcomes

$343,634
Jennifer S Haas · Brigham And Women'S Hospital · R01 · FY2007 · CA

MRI-Based Radiation Therapy Treatment Planning

$343,572
Ruijiang Li · Stanford University · R01 · FY2019 · CA

Project 3: Extending Clinical Benefit by Selective Treatment of Resistant Lesions in mCRPC

$343,526
Robert Jeraj · University Of Wisconsin-Madison · P50 · FY2023 · CA

Evaluation of immunotherapy-novel treatments in biochemically recurrent prostate

$343,422
Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Therapeutic Targeting of Wnt Signaling

$343,413
Dianqing Wu · Yale University · R01 · FY2009 · CA

CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res

$343,413
Alessandro D Santin · Yale University · R01 · FY2011 · CA

Therapeutic Targeting of Wnt Signaling

$343,413
Dianqing Wu · Yale University · R01 · FY2010 · CA

Exploiting Cancer Metabolism and Drug Efflux with Bystander-Assisted Immunotherapy

$343,396
Rock Mancini · Washington State University · R01 · FY2021 · CA

Gamma Delta T Cell Immunotherapy of Breast Cancer

$343,392
Richard D Lopez · University Of Alabama At Birmingham · P50 · FY2010 · CA

Project 2: Arsenic as an Endocrine Disruptor

$343,373
Joshua W Hamilton · Dartmouth College · P42 · FY2009 · ES

Nanotechnology enabled targeting of p53 deficiency in human cancer

$343,342
Xiaoming He · Univ Of Maryland, College Park · R01 · FY2019 · CA